Hepcidin and the BMP-SMAD pathway: An unexpected liaison
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Hepcidin, the main regulator of iron metabolism, is synthesized and released by hepatocytes in response to increased body iron concentration and inflammation. Deregulation of hepcidin expression is a common feature of genetic and acquired iron disorders: in Hereditary Hemochromatosis (HH) and iron-loading anemias low hepcidin causes iron overload, while in Iron Refractory Iron Deficiency Anemia (IRIDA) and anemia of inflammation (AI), high hepcidin levels induce iron-restricted erythropoiesis. Hepcidin expression in the liver is mainly controlled by the BMP-SMAD pathway, activated in a paracrine manner by BMP2 and BMP6 produced by liver sinusoidal endothelial cells. The BMP type I receptors ALK2 and ALK3 are responsible for iron-dependent hepcidin upregulation and basal hepcidin expression, respectively. Characterization of animal models with genetic inactivation of the key components of the pathway has suggested the existence of two BMP/SMAD pathway branches: the first ALK3 and HH proteins dependent, responsive to BMP2 for basal hepcidin activation, and the second ALK2 dependent, activated by BMP6 in response to increased tissue iron. The erythroid inhibitor of hepcidin Erythroferrone also impacts on the liver BMP-SMAD pathway although its effect is blunted by pathway hyper-activation. The liver BMP-SMAD pathway is required also in inflammation to cooperate with JAK2/STAT3 signaling for full hepcidin activation. Pharmacologic targeting of BMP-SMAD pathway components or regulators may improve the outcome of both genetic and acquired disorders of iron overload and deficiency by increasing or inhibiting hepcidin expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Two to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
A Red carpet for iron metabolism
Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017) · Cell · doi:10.1016/j.cell.2016.12.034 · Cited by 1,319
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
Research works printed but not linked: 59
- An, 2018, Smad7 deficiency decreases iron and haemoglobin through hepcidin up-regulation by multilayer compensatory mechanisms, Journal of Cellular and Molecular Medicine, 22, 3035, 10.1111/jcmm.13546 · DOI
- Antebi, 2017, Combinatorial signal perception in the BMP pathway, Cell, 170, 1184, 10.1016/j.cell.2017.08.015 · DOI · Paper page
- Arnold, 2006, Dose-dependent Smad1, Smad5 and Smad8 signaling in the early mouse embryo, Developmental Biology, 296, 104, 10.1016/j.ydbio.2006.04.442 · DOI · Paper page
- Artuso, 2018, Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice, Haematologica
- Asshoff, 2017, Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents, Blood, 129, 1823, 10.1182/blood-2016-09-740092 · DOI · Paper page
- Babitt, 2007, Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance, The Journal of Clinical Investigation, 117, 1933, 10.1172/JCI31342 · DOI · Paper page
- Besson-Fournier, 2017, Hepcidin upregulation by inflammation is independent of Smad1/5/8 signaling by activin B, Blood, 129, 533, 10.1182/blood-2016-10-748541 · DOI
- Canali, 2017, Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice, Blood, 129, 405, 10.1182/blood-2016-06-721571 · DOI · Paper page
- Casanovas, 2013, The murine growth differentiation factor 15 is not essential for systemic iron homeostasis in phlebotomized mice, Haematologica, 98, 444, 10.3324/haematol.2012.069807 · DOI · Paper page
- Castoldi, 2011, The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice, The Journal of Clinical Investigation, 121, 1386, 10.1172/JCI44883 · DOI · Paper page
- Chaikuad, 2012, Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva, The Journal of Biological Chemistry, 287, 36990, 10.1074/jbc.M112.365932 · DOI · Paper page
- Csiszar, 2006, Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype, The American Journal of Pathology, 168, 629, 10.2353/ajpath.2006.050284 · DOI
- Finberg, 2010, Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis, Blood, 115, 3817, 10.1182/blood-2009-05-224808 · DOI · Paper page
- Guo, 2013, Reducing TMPRSS6 ameliorates hemochromatosis and beta-thalassemia in mice, The Journal of Clinical Investigation, 123, 1531, 10.1172/JCI66969 · DOI · Paper page
- Kanamori, 2017, Interleukin-1beta (IL-1beta) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein delta (C/EBPdelta) expression in hepatocytes, The Journal of Biological Chemistry, 292, 10275, 10.1074/jbc.M116.770974 · DOI
- Kautz, 2011, Iron overload induces BMP6 expression in the liver but not in the duodenum, Haematologica, 96, 199, 10.3324/haematol.2010.031963 · DOI
- Kretzschmar, 1997, The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase, Genes & Development, 11, 984, 10.1101/gad.11.8.984 · DOI · Paper page
- Kuninger, 2008, Pro-protein convertases control the maturation and processing of the iron-regulatory protein, RGMc/hemojuvelin, BMC Biochemistry, 9, 9, 10.1186/1471-2091-9-9 · DOI · Paper page
- Kuns-Hashimoto, 2008, Selective binding of RGMc/hemojuvelin, a key protein in systemic iron metabolism, to BMP-2 and neogenin, American Journal of Physiology. Cell Physiology, 294, C994, 10.1152/ajpcell.00563.2007 · DOI
- Lai, 2018, Hepatic Smad7 overexpression causes severe iron overload in mice, Blood, 131, 581, 10.1182/blood-2017-07-796797 · DOI
- Latour, 2017, Deletion of BMP6 worsens the phenotype of HJV-deficient mice and attenuates hepcidin levels reached after LPS challenge, Blood, 130, 2339, 10.1182/blood-2017-07-795658 · DOI
- Latour, 2016, Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin, Hepatology, 63, 126, 10.1002/hep.28254 · DOI
- Layoun, 2018, MyD88 adaptor protein is required for appropriate Hepcidin induction in response to dietary iron overload in mice, Frontiers in Physiology, 9, 159, 10.3389/fphys.2018.00159 · DOI
- Lee, 2005, Regulation of hepcidin transcription by interleukin-1 and interleukin-6, Proceedings of the National Academy of Sciences of the United States of America, 102, 1906, 10.1073/pnas.0409808102 · DOI · Paper page
- Lee, 2010, Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis, Blood, 115, 3136, 10.1182/blood-2009-11-251199 · DOI
- Lin, 2008, Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site, Blood Cells, Molecules & Diseases, 40, 122, 10.1016/j.bcmd.2007.06.023 · DOI
- Mayeur, 2014, The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6, Blood, 123, 2261, 10.1182/blood-2013-02-480095 · DOI · Paper page
- McReynolds, 2007, Smad1 and Smad5 differentially regulate embryonic hematopoiesis, Blood, 110, 3881, 10.1182/blood-2007-04-085753 · DOI
- Meynard, 2009, Lack of the bone morphogenetic protein BMP6 induces massive iron overload, Nature Genetics, 41, 478, 10.1038/ng.320 · DOI · Paper page
- Mirciov, 2017, Characterization of putative erythroid regulators of hepcidin in mouse models of anemia, PLoS One, 12, 10.1371/journal.pone.0171054 · DOI
- Mirciov, 2018, Circulating iron levels influence the regulation of hepcidin following stimulated erythropoiesis, Haematologica, 103, 1616, 10.3324/haematol.2017.187245 · DOI
- Mleczko-Sanecka, 2010, SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression, Blood, 115, 2657, 10.1182/blood-2009-09-238105 · DOI
- Mleczko-Sanecka, 2017, Imatinib and spironolactone suppress hepcidin expression, Haematologica, 102, 1173, 10.3324/haematol.2016.162917 · DOI
- Nai, 2014, The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice, Haematologica, 99, 1016, 10.3324/haematol.2013.103143 · DOI
- Nicolas, 2002, Severe iron deficiency anemia in transgenic mice expressing liver hepcidin, Proceedings of the National Academy of Sciences of the United States of America, 99, 4596, 10.1073/pnas.072632499 · DOI · Paper page
- Niederkofler, 2005, Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload, The Journal of Clinical Investigation, 115, 2180, 10.1172/JCI25683 · DOI · Paper page
- Pagani, 2017, A new form of IRIDA due to combined heterozygous mutations of TMPRSS6 and ACVR1A encoding the BMP receptor ALK2, Blood, 129, 3392, 10.1182/blood-2017-03-773481 · DOI
- Pasricha, 2017, Hepcidin is regulated by promoter-associated histone acetylation and HDAC3, Nature Communications, 8, 403, 10.1038/s41467-017-00500-z · DOI
- Poli, 2014, Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo, Blood, 123, 1564, 10.1182/blood-2013-07-515221 · DOI
- Rausa, 2015, Bmp6 expression in murine liver non parenchymal cells: A mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?, PLoS One, 10, 10.1371/journal.pone.0122696 · DOI
- Robach, 2013, Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin, European Journal of Haematology, 91, 74, 10.1111/ejh.12122 · DOI
- Spiekerkoetter, 2015, Low-dose FK506 (tacrolimus) in end-stage pulmonary arterial hypertension, American Journal of Respiratory and Critical Care Medicine, 192, 254, 10.1164/rccm.201411-2061LE · DOI
- Spiekerkoetter, 2017, Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension, The European Respiratory Journal, 50, 1, 10.1183/13993003.02449-2016 · doi:10.1183/13993003.02449-2016
- Spiekerkoetter, 2013, FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension, The Journal of Clinical Investigation, 123, 3600, 10.1172/JCI65592 · DOI · Paper page
- Steinbicker, 2011, Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice, Blood, 118, 4224, 10.1182/blood-2011-03-339952 · DOI · Paper page
- Urist, 1970, Bone formation in implants of partially and wholly demineralized bone matrix. Including observations on acetone-fixed intra and extracellular proteins, Clinical Orthopaedics and Related Research, 71, 271, 10.1097/00003086-197007000-00031 · doi:10.1097/00003086-197007000-00031
- Vokurka, 2006, Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis, Physiological Research, 55, 667, 10.33549/physiolres.930841 · DOI · Paper page
- Vujic Spasic, 2013, Smad6 and Smad7 are co-regulated with hepcidin in mouse models of iron overload, Biochimica et Biophysica Acta, 1832, 76, 10.1016/j.bbadis.2012.08.013 · DOI
- Wahedi, 2017, Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway, The Journal of Biological Chemistry, 292, 18354, 10.1074/jbc.M117.801795 · DOI
- Wang, 2017, Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice, Blood, 130, 73, 10.1182/blood-2016-12-759423 · DOI · Paper page
- Wu, 2012, Repulsive guidance molecule (RGM) family proteins exhibit differential binding kinetics for bone morphogenetic proteins (BMPs), PLoS One, 7, 10.1371/journal.pone.0046307 · DOI
- Wu, 2014, HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression, Blood, 124, 1335, 10.1182/blood-2014-01-552281 · DOI · Paper page
- Xia, 2008, Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin, Blood, 111, 5195, 10.1182/blood-2007-09-111567 · DOI · Paper page
- Yang, 2014, Bone morphogenetic proteins: Relationship between molecular structure and their osteogenic activity, Food Science and Human Wellness, 3, 127, 10.1016/j.fshw.2014.12.002 · DOI
- Zhang, 2011, Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matriptase-2 protein, Blood, 117, 1687, 10.1182/blood-2010-06-287292 · DOI · Paper page
- Zhang, 2005, Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells, The Journal of Biological Chemistry, 280, 33885, 10.1074/jbc.M506207200 · DOI
- Zhang, 2009, Hemojuvelin-neogenin interaction is required for bone morphogenic protein-4-induced hepcidin expression, The Journal of Biological Chemistry, 284, 22580, 10.1074/jbc.M109.027318 · DOI
- Zhao, 2016, Neogenin facilitates the induction of hepcidin expression by hemojuvelin in the liver, The Journal of Biological Chemistry, 291, 12322, 10.1074/jbc.M116.721191 · DOI · Paper page
- Zumbrennen-Bullough, 2014, MicroRNA-130a is up-regulated in mouse liver by iron deficiency and targets the bone morphogenetic protein (BMP) receptor ALK2 to attenuate BMP signaling and hepcidin transcription, The Journal of Biological Chemistry, 289, 23796, 10.1074/jbc.M114.577387 · DOI
Cited by
Iron metabolism and iron disorders revisited in the hepcidin era
Camaschella, C., Nai, A., & Silvestri, L. (2020) · Haematologica · doi:10.3324/haematol.2019.232124 · Cited by 734
Self-citationHepcidin and Iron in Health and Disease
Nemeth, E., & Ganz, T. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-043021-032816 · Cited by 457
The Role of Iron Regulation in Immunometabolism and Immune-Related Disease
Cronin, S. J. F., Woolf, C. J., Weiss, G., & Penninger, J. M. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00116 · Cited by 299
Andolfo, I., Rosato, B. E., Manna, F., De Rosa, G., Marra, R., Gambale, A., Girelli, D., Russo, R., & Iolascon, A. (2020) · American Journal of Hematology · doi:10.1002/ajh.25683 · Cited by 61
Repulsive guidance molecules b (RGMb): molecular mechanism, function and role in diseases
Zhang, J., Jiang, Y., Zhang, Z., Li, S., Fan, H., Gu, J., Mao, R., & Xu, X. (2024) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2024.24 · Cited by 9
Metadata
- Authors
- Silvestri, L., Nai, A., Dulja, A., & Pagani, A.
- Venue
- Vitamins and Hormones
- Publisher
- Elsevier
- Published
- 2019
- Volume
- 110
- Pages
- 71-99
- ISSN
- 0083-6729 (ISSN-L)
- OpenAlex
- W2913615892
- Cited by
- 124
- References
- 49
- FWCI
- 33.17
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepcidin and the BMP-SMAD pathway: An unexpected liaison. https://app.cochat.ai/papers/10.1016/bs.vh.2019.01.004
- The paper
- Silvestri, L., Nai, A., Dulja, A., & Pagani, A. (2019). Hepcidin and the BMP-SMAD pathway: An unexpected liaison. Vitamins and Hormones. https://doi.org/10.1016/bs.vh.2019.01.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.